Effects of the Rho-Kinase Inhibitor Y-27632 on Extraocular Muscle Surgery in Rabbits

Figure 1

Immunohistochemical staining for Ki-67 (a), CD11 beta (b), and F4/80 (c) of the superior rectus muscle (SRM) 3 days after reinsertion of the SRM in a rabbit model: the normal saline injection group (above) and the Y-27632 injection group (below). Compared to the control group in which saline was injected into the SRM, only F4/80-positive areas were less present in the Y-27632 injection group (magnification, ×100). Immunepositive cells of Ki-67, CD11 beta, and F4/80 at 3 days after reinsertion of the SRM in a rabbit model (d).

(a)

(b)

(c)

(d)